SuperworthMustang Bio MBIO
- Market cap
- $2.7M
- PE
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- n/m
- not a meaningful number
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- n/m
- not a meaningful number
- Net margin
- n/m
- not a meaningful number
- Free cash flow yield
- n/m
- not a meaningful number
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D | $9.5M−38% | $6.2M−61% | $3.8M−73% | $4.4M−60% | $57K−99% | n/a | −$964K | $98K−98% | −$333K | n/a | $178K | $224K+129% |
| SG&A | $2.1M−37% | $2.2M−9% | $1.4M−39% | $1.5M−50% | $1.4M−34% | n/a | $1.2M−15% | $787K−49% | $957K−32% | n/a | $880K−28% | $946K+20% |
| −$10.3M−45% | −$8.7M−55% | −$5.2M−68% | −$8.5M−39% | −$1.5M−86% | n/a | −$253K−95% | −$885K−90% | −$624K−57% | n/a | −$1.1M+318% | −$1.2M+32% | |
| Interest expense | $4K−100% | −$3K | $1K−100% | $2K−100% | $1K−75% | $1K | n/a | n/a | n/a | n/a | n/a | n/a |
| Net income | −$10.1M−47% | −$8.6M−56% | −$5.2M−69% | −$8.2M−50% | −$1.4M−86% | −$952K−89% | −$153K−97% | −$762K−91% | −$468K−67% | n/a | −$955K+524% | −$1.1M+41% |
| −$61.50−49% | −$43.00−65% | −$24.81−76% | −$18.36−82% | −$1.96−97% | −$0.90−98% | −$0.05−100% | −$0.19−99% | −$0.07−96% | n/a | −$0.14+180% | −$0.16−16% | |
| 163.4K+4% | 200.1K+27% | 209.2K+29% | 446.6K+175% | 720.9K+341% | 1.1M+428% | 2.9M+1268% | 4M+800% | 6.2M+766% | 6.5M+511% | 6.7M+135% | 6.7M+67% |
R&D: Q2 FY15: 6 months less the 3 months printed beside them.
SG&A: Q2 FY15: 6 months less the 3 months printed beside them.
Operating income: Q2 FY15: 6 months less the 3 months printed beside them.
Interest expense: Q2 FY15: 6 months less the 3 months printed beside them.
Net income: Q2 FY15: 6 months less the 3 months printed beside them.
EPS, diluted: 6 periods, Q2 FY15 to Q4 FY24: quarter's net income to common over its shares, to the cent.
Diluted shares: Q2 FY15: share-days: the 6-month average less the second quarter's. 9 periods, Q4 FY16 to Q4 FY24: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Healthcare nearest Mustang Bio's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| MBIOMustang Bio | $2.7M | n/m | n/a | n/m | n/m | n/m | |
| OXBROXBRIDGE RE HOLDINGS | $7.7M | 47.5× | 9.6× | 2.8× | +40% | 4.7% | |
| EDUCEducational Development | $8.7M | 5.4× | 11.3× | 0.4× | −32% | 8.6% | |
| GTIMGood Times Restaurants | $13.6M | 6.1× | 13.6× | 0.1× | −6% | 1.7% | |
| MDRRMedalist Diversified | $15.4M | 2.5× | 3.0× | 1.6× | −1% | 80.2% | |
| BCGBinah Capital | $18.2M | 6.7× | 20.8× | 0.1× | +8% | 2.2% | |
| VIPVulcan Infrastructure & Power | $19.6M | 17.9× | 24.4× | 0.4× | −14% | 1.0% | |
| MXCMexco Energy | $20.5M | 13.4× | 13.3× | 3.0× | −9% | 23.3% | |
| CKXCKX Lands | $21.5M | 7.4× | 32.6× | 31.0× | −17% | n/m | |
| MSGMMotorsport Games | $22.5M | 11.4× | 11.5× | 1.5× | +79% | 16.2% | |
| ATCHAtlasClear | $24M | 15.8× | 17.5× | 1.2× | +85% | 9.8% | |
| Peer median | $18.9M | 9.4× | 13.4× | 1.4× | −3% | 8.6% |
More on Mustang Bio
Each number over time
Its groups
About
- Industry
- Drug Manufacturers - General
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .